Meracus Pharmaceuticals Private Limited
About Meracus Pharmaceuticals Private Limited
Data last updated:
Meracus Pharmaceuticals Private Limited is a private limited company based in Kolkata, West Bengal, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 29 July 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Kolkata, under CIN U36912WB2015PTC207253. Its GSTIN is 08AAJCM8453F1Z6 (Rajasthan).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Ankur Sharma and Priyanka Acharya.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 23/24 William Carey Sarani Formerly Radha Bazar Street, Kolkata, West Bengal, India – 700001.
As per the financials filed for FY 2024, the company reported a revenue of ₹62 Lakh, a growth of 31% compared to the previous year. For the same year it recorded a net profit of ₹72,615 (net margin 1.2%) and EBITDA of ₹1.41 Lakh (EBITDA margin 2.3%). Revenue has grown at a compounded annual rate (CAGR) of 27% over three years and 23% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Meracus Pharmaceuticals Private Limited's registered office is in Kolkata, West Bengal. Its e-mail address is in the company report.
- Email
- Registered Address23/24 William Carey Sarani Formerly Radha Bazar Street, Kolkata, West Bengal, India – 700001
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Meracus Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Meracus Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Meracus Pharmaceuticals Private Limited, buy the company report.
Financials of Meracus Pharmaceuticals Private Limited
FY 2025 filings availableMeracus Pharmaceuticals Private Limited reported revenue of ₹62 Lakh (up 31% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 23% over five years, including 31% growth in the latest year. EBITDA rose 37% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.41 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹72,615 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.3% | ||||
| Net Profit Margin | 1.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Meracus Pharmaceuticals Private Limited, buy the company report.
Board of directors of Meracus Pharmaceuticals Private Limited
Meracus Pharmaceuticals has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ankur Sharma | Director | 15 Jun 2018 | 8 Years 4 Months | Current |
| Priyanka Acharya | Director | 05 Aug 2019 | 7 Years 2 Months | Current |
Peer comparison
Meracus Pharmaceuticals Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Mezon Pharmaceuticals Private Limited | ₹62.12 Lakh (FY 2024) | -16.0% | Ludhiana, Punjab, India | |||
| Kaansla Pharmaceuticals Private Limited | ₹62.11 Lakh (FY 2025) | 58.0% | Panchkula, Haryana, India | |||
| Resilio Pharmaceuticals Private Limited | ₹62.1 Lakh (FY 2024) | 10.0% | Hyderabad, Telangana, India | |||
| Meracus Pharmaceuticals Private Limitedthis company | ₹62 Lakh (FY 2024) | ₹72,615 | 1.2% | 31.0% | Kolkata, West Bengal, India | |
| Avinatural Herbal Private Limited | ₹61.93 Lakh (FY 2024) | -25.0% | Delhi, India | |||
| Jaladhi Itra Occation Plus Healthcare India Private Limited | ₹61.81 Lakh (FY 2025) | 103.0% | Hyderabad, Telangana, India |
To see the full peer comparison of Meracus Pharmaceuticals Private Limited, buy the company report.
Auditor
Meracus Pharmaceuticals Private Limited is audited by DAIYA TIWARI & SONI for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| DAIYA TIWARI & SONI | FY 2017 | 004268C |
Shareholding
The shareholding of Meracus Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Meracus Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Meracus Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Meracus Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Meracus Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 08AAJCM8453F1Z6 | Rajasthan | Active | 15 Jan 2018 |
To see the full GST registrations and return filing status of Meracus Pharmaceuticals Private Limited, buy the company report.
Recent activity
Meracus Pharmaceuticals Private Limited has 4 board changes on record since 2018: 2 appointments and 2 cessations. The latest: Narendra Kumar Vyas ceased to be Director on 12 Oct 2020.
Frequently asked questions
Meracus Pharmaceuticals is an active private limited company based in Kolkata, West Bengal, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 29 July 2015 (11+ years old) and is registered under CIN U36912WB2015PTC207253.
Meracus Pharmaceuticals has 2 current directors:
- Ankur Sharma - Director
- Priyanka Acharya - Director
The latest financial statements of Meracus Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2016 are in the company report.
The GSTIN of Meracus Pharmaceuticals is 08AAJCM8453F1Z6, registered in Rajasthan.
The CIN (Corporate Identification Number) of Meracus Pharmaceuticals is U36912WB2015PTC207253. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Meracus Pharmaceuticals was incorporated on 29 July 2015, making it 11+ years old. It is registered with the Registrar of Companies, Kolkata.
The peers of Meracus Pharmaceuticals by revenue are Mezon Pharmaceuticals Private Limited, Kaansla Pharmaceuticals Private Limited, Resilio Pharmaceuticals Private Limited, Avinatural Herbal Private Limited, Jaladhi Itra Occation Plus Healthcare India Private Limited, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading).
Narendra Kumar Vyas ceased to be Director on 12 Oct 2020. Priyanka Acharya was appointed as Director on 05 Aug 2019. Sujit Acharya ceased to be Director on 16 Jun 2018. Meracus Pharmaceuticals has 4 board changes on record in total.
The registered office of Meracus Pharmaceuticals is at 2324 William Carey Sarani Formerly Radha Bazar Street, Kolkata, West Bengal, India – 700001.
Meracus Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
The compliance status of Meracus Pharmaceuticals is compliant as of 08 September 2026. The company is actively filing with the Registrar of Companies.